Halvard Bönig
- Hematology top 0.5%
- Hematopoietic Stem Cell Transplantation 76
- Immunology top 2%
- Immune Cell Function and Interaction 43
- Immunotherapy and Immune Responses 23
- T-cell and B-cell Immunology 15
- Oncology top 1%
- CAR-T cell therapy research 51
- Neutropenia and Cancer Infections 14
- Genetics top 1%
- Mesenchymal stem cell research 25
- Virus-based gene therapy research 20
- Genetics top 5%
- Mesenchymal stem cell research 25
- Virus-based gene therapy research 20
- Co-authors
- Thalia PapayannopoulouErhard SeifriedGregory V. PriestleyDarja KarpovaDieter KörholzHeike BialleckSusanne BräuningerT Papayannopoulou
- Cited by
- HematologyImmunologyOncology
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Halvard Bönig
203 papers receiving 4.6k citations
Peers
Comparison fields: 5 of 122
- Hematology 1.6k
- Immunology 1.4k
- Oncology 1.7k
- Genetics 676
- Genetics 686
Countries citing papers authored by Halvard Bönig
This map shows the geographic impact of Halvard Bönig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Halvard Bönig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Halvard Bönig more than expected).
Fields of papers citing papers by Halvard Bönig
This network shows the impact of papers produced by Halvard Bönig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Halvard Bönig. The network helps show where Halvard Bönig may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Halvard Bönig, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 8 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 0 | |
| 8 | 2023 | 4 | |
| 9 | 2022 | 11 | |
| 10 | 2022 | 11 | |
| 11 | 2022 | 9 | |
| 12 | 2021 | 74 | |
| 13 | 2020 | 3 | |
| 14 | 2018 | 15 | |
| 15 | 2016 | 8 | |
| 16 | 2015 | 22 | |
| 17 | 2014 | 56 | |
| 18 | 2014 | 15 | |
| 19 | 2008 | 9 | |
| 20 | 1999 | 13 |
About Halvard Bönig
Halvard Bönig is a scholar working on Hematology, Immunology and Oncology, having authored 210 papers that have together received 4.7k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (76 papers), CAR-T cell therapy research (51 papers), Immune Cell Function and Interaction (43 papers), Mesenchymal stem cell research (25 papers), Immunotherapy and Immune Responses (23 papers), Virus-based gene therapy research (20 papers), T-cell and B-cell Immunology (15 papers) and Neutropenia and Cancer Infections (14 papers). The work is most often cited by research in Hematology (1.6k citations), Immunology (1.4k citations) and Oncology (1.7k citations). Halvard Bönig has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Thalia Papayannopoulou, Erhard Seifried, Gregory V. Priestley, Darja Karpova, Dieter Körholz, Heike Bialleck, Erhard Seifried, Susanne Bräuninger, T Papayannopoulou and Beate Luxembourg. Their work appears in journals such as Blood, Journal of Translational Medicine, Cytotherapy, Transfusion and Bone Marrow Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.